NCT Number: NCT04663919
In this study, when patients diagnosed with AN started treatment and their weight increased by 10%; On the other hand, it was aimed to compare the changes in serum adipokine levels observed in morbidly obese patients before bariatric surgery and when they lost 10% of their post-op weight with both anthropometric measurements, biochemical parameters, and values of healthy volunteers.
Looking for future studies?
Notify Me13 year–60 year
All sexes
Interventional
Not applicable
The most characteristic feature of obesity is the increase in adipose tissue. On the contrary, in anorexia nervosa, there is a decrease in adipose tissue enough to impair neuroendocrine functions. Adipose tissue is formed by loosely binding lipid-filled cells called adipocytes and is now considered an important part of energy metabolism. Adipokines it secretes play a role in many physiological processes of the body such as nutrition, appetite, energy balance, insulin, and glucose metabolism, lipid metabolism, regulation of blood pressure, vascular remodeling, coagulation, and inflammation.
Therefore, changes in the amount of body fat in these two patient groups, which are at the two ends of the spectrum, affect both the biochemical parameters and physiological functions of the patients in different ways. It is expected that both adipokine levels and biochemical parameters will approach the values of healthy subjects with a decrease in adipose tissue of clinically morbidly obese patients and an increase in adipose tissue of patients with AN. However, in some studies comparing the parameters of patients with constitutionally weak patients and patients with AN, results contrary to expectations were obtained. In this study, we compared the extent to which weight changes changed adipokines and correlated with biochemical parameters based on healthy and normal-weight volunteers.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
After the creation of a 15-25-cc gastric pouch from the upper stomach, transection of proximal jejunum 70 cm from Treitz ligament also called "alimentary tract" and anastomosis of the distal end of jejunum to the gastric pouch, and thereafter, anastomosis of the proximal end of transected jejunum to the distal part of the jejunum at 150 cm below the site of transection (jejunoileal anastomosis).
High-calorie medical nutrition program to ensure weight gain
Time frame: 3 months on average
Change in baseline Leptin levels at when decreasing by 10 percent or increasing by 10 percent from initial weight. Measured by plasma samples.
Time frame: 3 months on average
Change in baseline Apelin levels at when decreasing by 10 percent or increasing by 10 percent from initial weight. Measured by plasma samples.
Time frame: 3 months on average
Change in baseline Omentin levels at when decreasing by 10 percent or increasing by 10 percent from initial weight. Measured by plasma samples.
Time frame: 3 months on average
Change in baseline Adiponectin levels at when decreasing by 10 percent or increasing by 10 percent from initial weight. Measured by plasma samples.
Time frame: 3 months on average
Change in baseline IL-6 levels at when decreasing by 10 percent or increasing by 10 percent from initial weight. Measured by plasma samples.
Time frame: 3 months on average
Change in baseline weight (kg) at when decreasing by 10 percent or increasing by 10 percent from initial weight.
Time frame: 3 months on average
Change in baseline fat mass (kg) at when decreasing by 10 percent or increasing by 10 percent from initial weight.
Time frame: 3 months on average
Change in baseline fat free mass (kg) at when decreasing by 10 percent or increasing by 10 percent from initial weight.
Time frame: 3 months on average
Change in baseline glucose (mg/dl) at when decreasing by 10 percent or increasing by 10 percent from initial weight.
Time frame: 3 months on average
Change in baseline insulin (µU/mL) at when decreasing by 10 percent or increasing by 10 percent from initial weight.
Time frame: 3 months on average
Change in baseline CRP at when decreasing by 10 percent or increasing by 10 percent from initial weight.
Istanbul University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04127214
Anorexia Nervosa, Binge Eating
Argentona, Catalonia, Spain
View Trial DetailsNCT06345040
Anorexia Nervosa, Bulimia Nervosa
Hellerup, Copenhagen, Denmark
View Trial DetailsNCT06624150
Anorexia Nervosa, Atypical Anorexia Nervosa
Minneapolis, Minnesota, United States
View Trial DetailsNCT05184556
Anorexia Nervosa, Eating Disorders
Pittsburgh, Pennsylvania, United States
View Trial Details